Population Pharmacokinetics (PopPK) of Revumenib in Patients with Relapsed/Refractory Acute Leukemias | サターラ

Population Pharmacokinetics (PopPK) of Revumenib in Patients with Relapsed/Refractory Acute Leukemias

関連コンテンツ

How the US FDA MIDD paired pilot program helps sponsors

Combining mechanistic modeling with machine learning as a strategy to predict inflammatory bowel disease clinical scores

Behind the Science: A Conversation with Lamia Sid-Otmane

希少疾患の医薬品開発を加速するために必要なツール

製品紹介資料

Powered by Translations.com GlobalLink Web Software